{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Metoprine",
  "nciThesaurus": {
    "casRegistry": "7761-45-7",
    "chebiId": "",
    "chemicalFormula": "C11H10Cl2N4",
    "definition": "A diaminopyrimidine folate antagonist with potential antineoplastic activity.  Metoprine inhibits dihydrofolate reductase, resulting in decreased cellular folate metabolism and cell growth; it also inhibits histamine-N-methyltransferase, resulting in decreased histamine catabolism. Lipid-soluble metoprine is capable of crossing the blood-brain barrier.",
    "fdaUniiCode": "2L9RKX796Q",
    "identifier": "C1161",
    "preferredName": "Metoprine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2153",
      "C511"
    ],
    "synonyms": [
      "BW 197U",
      "DDMP",
      "METOPRINE",
      "Metoprine"
    ]
  }
}